Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.330
-0.190 (-12.50%)
At close: May 19, 2026, 4:00 PM EDT
1.380
+0.050 (3.76%)
Pre-market: May 20, 2026, 5:51 AM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $2.98 million as of May 20, 2026. Its market cap has decreased by -59.57% in one year.
Market Cap
2.98M
Enterprise Value
1.48M
1-Year Change
-59.57%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $2.98M, a decrease of -93.78%. That is a compound annual growth rate of -44.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 3.41M | -33.12% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CNS Pharmaceuticals | 4.02M |
| Akari Therapeutics, | 3.95M |
| Galmed Pharmaceuticals | 3.95M |
| Alzamend Neuro | 3.88M |
| VivoSim Labs | 3.73M |
| Soligenix | 3.71M |
| 60 Degrees Pharmaceuticals | 3.67M |
| Revelation Biosciences | 3.64M |